Industry Symposia
Friday, August 13
- Moderator: Dr. Diego Jaimes (COL)
- Long-Term Outcomes with Baricitinib in RA. Dr. Mario Cardiel (MEX)
- Real Life Evidence with Baricitinib. Dra. Rina Neubrath (BRA)
- Moderator: Dr. Wilson Bautista (COL)
- New treatment options for the patient with PsA. Dr. Diego Jaimes (COL)
- From theory to practice: A clinical case of PsA. Dr. Valderilio Azevedo (BRA)
- Chairman: Dr. Juan Moreno (Argentina)
- How I treat rheumatoid arthritis (Prof. Josef Smolen) – 30 min
- A practical approach considering Latin American reality: a debate (Prof. Josef Smolen, Prof. Eduardo Mysler, Prof. Morton Scheinberg) – 30 min
- 2021: The odyssey of the IL-23 pathway in early PsA (15 min). Dr. Dennis McGonagle (UK)
- Sharpening the tools: Role of US and MRI in the management of PsA in the clinical setting (15 min) Dr. Mikkel Ostergaard (Denmark)
- Putting imaging to practice with a focus on US: the current picture (15 min). Dr. Alen Zabotti (Italy)
- Q&As
Saturday, August 14
- Welcome and introduction (5 min)– Dr Fernando Sommerfleck
- Does the JAK-STAT pathway belong in the pathology of Spondyloarthritis (SpA)? (10 min) Dr Fernando Sommerfleck
- Deep Dive into SpA: Is there a place for JAK inhibitors? (30 min) Dr Rodrigo Luppino – Brazil
- Answers to the questions you’re dying to ask! (15 min) Dr Fernando Sommerfleck / Dr Rodrigo Luppino/ all
- Guidelines for the treatment of Psoriatic Arthritis. Dr. Enrique Soriano (20 min)
- Axial PsA: are we missing something? Dr. Xenofon Baraliakos (20 min)
- Q&A (20 min)
- Moderator: Dra. Lorena Brance – Argentina
- Speaker: Dr. Esteban Jodar (45 min) España
- Q&A (15 min)
